Topical imidazole-calcineurin inhibitor combination as an economical and efficacious treatment for dermatologic diseases.
Feily
Amir
A
Khalesi
Mohammad
M
Namazi
Mohammad Rerza
MR
D000279:Administration, Cutaneous; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000627:therapeutic use*; D065095:Calcineurin Inhibitors; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004338:Drug Combinations; D006801:Humans; D007093:Imidazoles / Q000378:metabolism / Q000627:therapeutic use*; D007223:Infant; D012871:Skin Diseases / Q000188:drug therapy*; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D065095:Calcineurin Inhibitors; D065607:Cytochrome P-450 Enzyme Inhibitors; D004338:Drug Combinations; D007093:Imidazoles; C117268:pimecrolimus; D003577:Cytochrome P-450 Enzyme System; D016559:Tacrolimus